Economy – Page 109 – IL BIOECONOMISTA

Biotec and Kaneka together to create new bio-based compounds

20 February 2015Il BioeconomistaLeave a comment

There is a new partnership in the world bioeconomy. German Biotec GmbH and Japanese Kaneka Corporation signed a broad Joint Development Agreement for the application of biopolymers. Biotec develops and manufactures bio-based, biodegradable and compostable compounds under the trade name Bioplast. Kaneka is the producer of a 100% bio based and innovative PHBH polymer with the brand name Aonilex, which is new to the market. Both companies agreed to combine development resources to create new bio-based compounds for the application fields of pharmaceutical capsules, extrusion coated paper and cardboard, various other flexible and rigid films and packaging solutions.

Continue reading →

Bio-on and Eridania Sadam develop together bio-based levulinic acid

18 February 201518 February 2015Il Bioeconomista1 Comment

The Italian bioeconomy is growing. Bio-on, an innovative industrial biotech company, and Eridania Sadam, sub-holding of the agro-food sector owned by the Maccaferri Group of Bologna, will work together on defining and optimising the production of levulinic acid, a key molecule for the sustainable and low-impact future of the chemical industry. Already available on the international market, but in insufficient quantities, levulinic acid is currently obtained from industrial processes with an environmental impact that fails to meet European standards.

Continue reading →

BP Energy Outlook: global demand for energy is expected to rise by 37% from 2013 to 2035

18 February 201518 February 2015Il BioeconomistaLeave a comment

Vivergo (JV between BP, Dupont and ABSugar) bioethanol plant in Hull (England)

Despite the dramatic recent weakening in global energy markets, ongoing economic expansion in Asia – particularly in China and India – will drive continued growth in the world’s demand for energy over the next 20 years. According to the new edition of the BP Energy Outlook 2035, global demand for energy is expected to rise by 37% from 2013 to 2035, or by an average of 1.4% a year.

Continue reading →

Still together for the bioeconomy revolution

14 February 201518 February 2015Il BioeconomistaLeave a comment

Former EU Commissioner Máire Geoghegan-Quinn speaks to delegates during the Bioeconomy conference in Dublin on February 14, 2013.

Dear Readers,

let me talk about us, to share with you an acknowledgment that we are very pleased to receive. Our blog is considered a model to follow in a scientific paper entitled “Gearing Modeling of Regional Eco-Bio-Logistic Components in Bioeconomic Management, Using Arena Simulation Software”, written by Claudiu Pîrnău, a researcher of the University of Sibiu (Romania), and presented last year at the Scientific Papers International Conference on Knowledge Society.

Continue reading →

The European Biopreferred is coming

13 February 201513 February 2015Il BioeconomistaLeave a comment

Wageningen UR Food & Biobased Research investigates standards for biobased products as part of the Open-Bio project commissioned by the EU. There is some ambiguity concerning bio-based products which frequently have different functional properties and end-of-life options from petroleum-based products. To develop and improve these standards, however, misconceptions will first have to be identified and eliminated. Clear standards will help to remove barriers to the introduction of bio-based products on the market.

Continue reading →

British Synthace closes a £2.2 million funding round

11 February 201511 February 2015Il BioeconomistaLeave a comment

Investment funds are looking with more attention to the bioeconomy. British bioengineering firm Synthace has closed a £2.2 million funding round with new investors SOSventures, Bioeconomy Capital and Rainbow Seed Fund joining Sofinnova Partners and other existing investors.

Continue reading →

VWR achieves a new acquisition in the high growth biochemical industry

10 February 2015Il BioeconomistaLeave a comment

VWR, a US leading, independent provider of laboratory products, services and solutions, announced that it has acquired National Biochemicals (NBC), a full service raw material manufacturer and supplier to the biochemical industry. This acquisition will enhance VWR’s growing custom chemical and biochemical manufacturing portfolio, building upon previous successful acquisitions in this segment.

Continue reading →

Global Bioenergies reaches the first milestone of the BioMA+ project

6 February 2015Il BioeconomistaLeave a comment

Marc Delcourt, co-founder and CEO of Global Bioenergies

French Global Bioenergies, one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation, announces having reached the first milestone of the BioMA+ project which is financed by the French “Investissements d’Avenir” State program. The project aims at developing a renewable value chain to methacrylic acid, a key constituent of acrylic paints. Achieving this first milestone result unlocks a €1.7 million payment.

Continue reading →

Evonik achieves a breakthrough in the biotechnological production of amino acids based on fermentation

5 February 20155 February 2015Il BioeconomistaLeave a comment

Using creativity and unconventional ideas, researchers and engineers at Evonik, one of the world leaders in specialty chemicals, have achieved a significant breakthrough in the biotechnological production of amino acids based on fermentation. They integrated the separating methods of chromatography and reverse osmosis and an online analytical method based on spectroscopy—all of which tend to be used in other industry sectors—in a biotechnological process. This created an outcome experts had previously considered nearly impossible. The researchers’ objective was to achieve optimal separation of the desired amino acid from a fermentation broth.

Continue reading →

DSM invests in US manufactoring facility for sustainable resins

3 February 2015Il Bioeconomista1 Comment

Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, the global Life Sciences and Materials Sciences company headquartered in The Netherlands, announced yesterday a “substantial investment” in its Wilmington, Massachusetts (USA) manufacturing facility in order to produce waterborne resins for inks and coatings. Driven by its commitment to grow the sustainable coatings market, DSM will
upgrade its facilities to produce state-of-the-art waterborne resins for inks and coatings.

Continue reading →